Zymeworks Inc.
ZYMENASDAQHealthcareBiotechnology
As of Oct 23, 2026 close
- Market cap
- $2.06B
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $16.00$31.34
- Volume (live)
- -
- Avg. volume (3M)
- 1.15M
Zymeworks (ZYME) Stock Price & Financial Analysis
Zymeworks Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $27.28 - $28.77 |
|---|---|
| 52-Week High | $31.34 |
| 52-Week Low | $16.00 |
| Open | $28.77 |
| Volume (last close) | 1.12M |
| Average Volume (3M) | 1.15M |
| Revenue (TTM) | 37.13M |
|---|---|
| Net Income (TTM) | -149.99M |
| Free Cash Flow (TTM) | -120.26M |
| EPS (TTM) | −$2.01 |
| Profit Margin | -404.00% |
| Operating Margin | -418.90% |
| Return on Equity (ROE) | -186.63% |
| Debt to Equity | 0.20 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
| Market Cap | 2.06B |
|---|---|
| Shares Outstanding | 72.99M |
| Price to Sales (P/S) | 55.48 |
| Price to Book (P/B) | 25.63 |
| EV/EBITDA | -13.81 |
| 50-Day MA | $26.84 |
|---|---|
| 200-Day MA | $25.04 |
| 1-Year Change | +63.35% |
Source: Market prices and company fundamentals. Data as of Oct 23, 2026. Data sources and methodology
Zymeworks at a Glance
As of the Oct 23, 2026 close, Zymeworks (ZYME) has a market capitalization of $2.06B. The stock trades at 55.5× sales. Over the trailing twelve months it lost $149.99M on revenue of $37.13M and burned $120.26M of free cash flow. Revenue fell 69.8% year over year.
As of its latest reported balance sheet, it holds $179.41M in cash and securities against $16.01M of debt, a net cash position of $163.41M.
Zymeworks does not currently pay a dividend.
The share price is up 63.4% over the past year. At $28.22 (the Oct 23, 2026 close) it sits within its 52-week range of $16.00 to $31.34, above its 200-day moving average of $25.04.
Based on 14 professional analyst ratings from the past 90 days, the consensus is Buy with an average price target of $40.83, 44.7% above the Oct 23, 2026 close.
Frequently Asked Questions About Zymeworks
What is the current stock price for ZYME?
As of the Oct 23, 2026 close, ZYME stock trades at $28.22. The 52-week range is $16.00–$31.34, with a day range of $27.28–$28.77.
What is the P/E ratio for ZYME?
The P/E ratio (Price-to-Earnings) for ZYME is shown in the Key Statistics section. This valuation metric helps compare Zymeworks Inc. to industry peers.
Does ZYME pay dividends?
Zymeworks does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for ZYME?
Based on ratings from 14 professional analysts over the last 90 days, the consensus for ZYME is Buy. The average 12-month price target is $40.83, a 44.7% upside from the Oct 23, 2026 close of $28.22.
What is the market cap of ZYME?
As of the Oct 23, 2026 close, Zymeworks's market capitalization is $2.06B, classifying it as a mid-cap company. Zymeworks operates in the Healthcare sector within the Biotechnology industry.